Design and synthesis of conformationally constrained inhibitors of high- affinity, sodium-dependent glutamate transporters

Methods in Enzymology

Volumn 296, Issue , 1998, Pages 175-189

  Chamberlin, A Richard ^a   Koch, Hans P ^a   Bridges, Richard J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR ANTAGONIST; NEUROTRANSMITTER RECEPTOR;

ANIMAL TISSUE; BINDING AFFINITY; BINDING SITE; CONFORMATIONAL TRANSITION; DRUG DESIGN; DRUG SYNTHESIS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SYNAPTOSOME;

ANIMALIA;

EID: 0031660297     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(98)96014-1     Document Type: Article

References (28)

1. A. R. Chamberlin and R. J. Bridges, "Conformationally Constrained Acidic Amino Acids as Probes of Glutamate Receptors and Transporters." Raven, New York, 1993.
2. A. Schousboe, P. Larsson, P. Krogsgaard-Larsen, J. Drejer, and L. Hertz, in "The Biochemical Pathology of Astrocytes," pp. 381-394. Alan R. Liss, New York, 1987.
3. P. J. Roberts and J. C. Watkins, Brain Res. 85, 120 (1975).
4. R. J. Bridges, M. S. Stanley, M. W. Anderson, C. W. Cotman, and A. R. Chamberlin, J. Med. Chem. 34, 717 (1991).
5. E. J. Fletcher, K. N. Mewett, C. A. Drew, R. D. Allan, and G. A. R. Johnston, Neurosci. Lett. 121, 133 (1991).
6. Y. Nakamura, K. Kataoka, M. Ishida, and H. Shinozaki, Neuropharmacol. 32, 833 (1993).
7. N. S. Ham, in "Molecular and Quantum Pharmacology" (E. Bergmann and B. Pullman, Eds.), pp. 261-268. D. Riedel, Dordrecht-Holland, 1974.
8. N. C. Cohen, J. M. Blaney, C. Humblet, P. Gund, and D. C. Barry, J. Med. Chem. 33, 883 (1990).
9. S. J. Weiner, P. A. Kollman, D. A. Case, U. C. Singh, C. Ghio, G. Alagona, S. Profeta, Jr., and P. Weiner, J. Am. Chem. Soc. 106, 765 (1984).
10. W. D. Cornell, P. Cieplak, C. I. Bayly, I. R. Gould, K. M. Merz, Jr., D. M. Ferguson, D. C. Spellmeyer, T. Fox, J. W. Caldwell, and P. A. Kollman, J. Am. Chem. Soc. 117, 5179 (1995).
11. G.R. Marshall and I. Motoc, in "Molecular Graphics and Drug Design, Topics in Molecular Pharmacology" (A. S. V. Burgen, G. C. K. Roberts, and M. S. Tute, Eds.), p. 115. Elsevier, Amsterdam, 1986.
12. F. Lovering, Ph.D Dissertation, University of California, Irvine, 1993.
13. J. M. Humphrey, R. J. Bridges, J. A. Hart, and A. R. Chamberlin, J. Org. Chem. 59, 2467 (1993).
14. R. J. Bridges, F. E. Lovering, H. Koch, C. W. Cotman, and A. R. Chamberlin, Neurosci. Lett. 174, 193 (1994).
15. C. S. Esslinger, H. P. Koch, M. P. Kavanaugh, D. P. Philips, A. R. Chamberlin, C. M. Thompson, and R. J. Bridges, Bioorg. Med. Chem. Lett., submitted (1998).
16. C. L. Willis, D. L. Dauenhauer, J. M. Humphrey, A. R. Chamberlin, A. L. Buller, D. T. Monaghan, and R. J. Bridges, Toxicol. App. Pharmacol. 144, 45 (1997).
17. H. P. Koch, S. Esslinger, A. R. Chamberlin, and R. J. Bridges, Society for Neuroscience Abstracts 22, Abs. #619.6.
18. V. Balcar and G. Johnston, J. Neurochem. 19, 2657 (1972).
19. A. Garlin, A. Sinor, S. Lee, J. Grinspan, and M. Robinson, J. Neurochem. 64, 2572 (1995).
20. M. B. Robinson, Methods Enzymol. 296, [13], (1998) (this volume).
21. R. F. G. Booth and J. B. Clark, Biochem. J. 176, 365 (1978).
22. M. J. Kuhar and M. Zarbin, J. Neurochem. 31, 251 (1978).
23. H. Christensen, "Biological Transport." W. A. Benjamin, Reading, Massachusetts, 1975.
24. A. Cha, N. Zerangue, M. Kavanaugh, and F. Bezanilla, Methods Enzymol. 296, [38], (1998) (this volume).
25. J. L. Arriza, W. A. Fairman, J. I. Wadiche, G. H. Murdoch, M. P. Kavanaugh, and S. G. Amara, J. Neurosci. 14, 5559 (1994).
26. M. Erecinska and M. Troeger, FEBS Lett. 199, 95 (1986).
27. R. Griffiths, J. Dunlop, A. Gorman, J. Senior, and A. Grieve, Biochem. Pharmacol. 47, 267 (1994).
28. C. L. Willis, J. M. Humphrey, H. P. Koch, J. A. Hart, T. Blakely, L. Ralston, C. A. Baker, S. Shim, M. Kadri, A. R. Chamberlin, and R. J. Bridges, Neuropharmacol. 35, 5531 (1996).